The cost will likely ... in the lens of the eye that develops in people after the age of 40, and affects an estimated 128 million people in the US. AbbVie is recommending Vuity primarily for ...

While other experimental eye drops with similar effects are still undergoing clinical trials, Vuity is the first to receive FDA approval, marking an important step forward in treating presbyopia.

The US has approved a new type of eye drop which ... studies that Vuity was observed to start working within 15 minutes of application. In a positive piece of news, the drops were found to result ...